Skip to main content
B

BOTANIX PHARMACEUTICALS LTD — Investor Relations & Filings

Ticker · BOT ISIN · AU000000BOT2 ASX Manufacturing
Open in API
Filings indexed 1,201 across all filing types
Latest filing 2026-04-23 Director's Dealing
Country AU Australia
Listing ASX BOT

About BOTANIX PHARMACEUTICALS LTD

https://botanixpharma.com/

Botanix Pharmaceuticals Ltd is a clinical-stage pharmaceutical company focused on the development and commercialization of novel topical treatments for serious skin conditions. The company utilizes its proprietary Permetrex™ skin delivery technology, which is designed to improve the delivery of active ingredients through the skin. Its primary product, Sofdra™ (sofpironium bromide), is an FDA-approved prescription topical gel for the treatment of primary axillary hyperhidrosis. The company's research and development pipeline also includes clinical-stage candidates for the treatment of acne, rosacea, and atopic dermatitis. Botanix aims to address significant unmet medical needs in dermatology by providing innovative therapeutic solutions with enhanced safety and efficacy profiles.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice x5 13 pages 506.9KB
Director's Dealing Classification · 1% confidence The document is an ASX Appendix 3Y Change of Director’s Interest Notice under Listing Rule 3.19A.2. It details multiple directors’ personal securities transactions (performance rights, options, shares) and changes in their interests. This corresponds to insider share dealings by directors. Hence, this fits the Director’s Dealing category.
2026-04-23 English
Botanix Webinar - 29 April - Registration Information 2 pages 160.4KB
Regulatory Filings Classification · 1% confidence The document is a brief announcement inviting investors to register for a company webinar. It does not contain actual financial results, a presentation deck, a report, or any regulatory voting/management change content. It is an event notification that does not fit any specific filing category, so it falls into the catch-all Regulatory Filings category (RNS).
2026-04-20 English
Application for quotation of securities - BOT 8 pages 20.9KB
Share Issue/Capital Change Classification · 1% confidence The document is the ASX “Appendix 2A – Application for quotation of securities,” detailing the number, type, issue date, issue price, and post-quotation capital structure following a new equity issuance under a share purchase plan. It is not an annual or interim report, earnings release, management commentary, or AGM material, but rather an official notice of a new share issue and the quotation of those securities. This matches the “Share Issue/Capital Change” category (SHA).
2026-04-19 English
Notification regarding unquoted securities - BOT 8 pages 23.3KB
Share Issue/Capital Change Classification · 1% confidence The document is an ASX Appendix 3G notification concerning the issue of unquoted equity securities (options). It is a formal announcement of new capital issuance (share options), fitting the definition of a Share Issue/Capital Change. Therefore, the correct classification is SHA.
2026-04-19 English
Notification of cessation of securities - BOT 5 pages 16.7KB
Share Issue/Capital Change Classification · 1% confidence The document is an ASX ‘Appendix 3H – Notification of cessation of securities’ which formally notifies the market of changes to the company’s issued capital (options expiring and ceasing). This is a corporate capital structure change announcement rather than an earnings release, AGM material, management change, or investor presentation. It falls under the Share Issue/Capital Change category (SHA).
2026-04-16 English
Completion of Security Purchase Plan 2 pages 268.9KB
Share Issue/Capital Change Classification · 1% confidence The document is an ASX release announcing the completion of a Security Purchase Plan (SPP), detailing new share and option issuances, underwritten amounts, and capital raised. It specifically relates to the issuance of new securities (shares and options) under the SPP and placement. This is not a general earnings release or report publication notice but a capital raising and share issuance announcement. According to the classification definitions, this fits ‘Share Issue/Capital Change’ (Code: SHA), which covers announcements regarding new share issues and capital structure changes.
2026-04-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.